FRANKFURT (Dow Jones)--The following is a summary of analysts' forecasts for AstraZeneca plc's (AZN) second-quarter results, based on a poll of 10 analysts by Dow Jones Newswires (in million USD, EPS, dividend in USD, target price in pence, according to IFRS). Earnings figures are scheduled to be released July 29. === Sales Sales Sales Sales Operat. 2nd Quarter total Nexium Seroquel Symbicort profit AVERAGE 8,030 1,191 1,340 681 2,878 Prev. Year 7,958 1,246 1,249 551 2,851 +/- in % +0.9 -4.4 +7.3 +24 +0.9 MEDIAN 8,014 1,181 1,338 677 2,883 Maximum 8,293 1,240 1,395 740 3,059 Minimum 7,835 1,131 1,299 638 2,739 Amount 10 9 9 9 7 Bernstein 7,951 -- -- -- -- Carnegie 7,892 1,161 1,299 694 2,739 Citigroup 8,118 1,179 1,395 680 -- Credit Suisse 7,835 1,131 1,355 638 2,883 Deutsche Bank 7,931 1,155 1,321 672 2,782 Helvea 7,983 1,232 1,366 677 2,833 Jefferies 8,044 1,181 1,306 668 -- Oddo 8,194 1,240 1,350 700 3,059 Swedbank 8,062 1,225 1,338 657 2,912 UBS 8,293 1,214 1,331 740 2,936 Pretax Net attrib. EPS ord. Div./Share Target profit profit share 2010 Price Rating AVERAGE 2,752 1,942 1.35 2.49 3,274 Prev. Year 2,608 1,707 1.18 2.30 n.a. +/- in % +5.5 +14 +14 +8.3 n.a. MEDIAN 2,761 1,941 1.35 2.46 3,119 Maximum 2,929 2,072 1.44 2.66 4,100 Minimum 2,619 1,834 1.27 2.37 2,900 Amount 6 7 7 7 5 Carnegie 2,619 1,834 1.27 2.37 -- Outperform Citigroup -- -- -- 2.61 -- Hold Credit Suisse 2,733 1,941 1.35 2.46 3,119 Neutral Deutsche Bank 2,637 1,849 1.28 2.43 3,000 Hold Helvea -- 1,904 1.32 -- 3,250 Accumulate Jefferies -- -- -- 2.40 2,900 Hold Oddo 2,929 2,072 1.44 -- -- -- Swedbank 2,805 2,048 1.41 2.50 -- -- UBS 2,788 1,948 1.35 2.66 4,100 Buy === Year-earlier figures are as reported by the company. DJG/sag (END) Dow Jones Newswires July 26, 2010 10:22 ET (14:22 GMT)